𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical and Pathological Characteristics ofLRRK2G2019S Patients with PD

✍ Scribed by Markos Poulopoulos; Etty Cortes; Jean-Paul G. Vonsattel; Stanley Fahn; Cheryl Waters; Lucien J. Cote; Carol Moskowitz; Lawrence S. Honig; Lorraine N. Clark; Karen S. Marder; Roy N. Alcalay

Book ID
113093554
Publisher
Humana Press Inc
Year
2011
Tongue
English
Weight
353 KB
Volume
47
Category
Article
ISSN
0895-8696

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Genetic and clinical identification of P
Genetic and clinical identification of Parkinson's disease patients with LRRK2 G2019S mutation
✍ Hao Deng; Weidong Le; Yi Guo; Christine B. Hunter; Wenjie Xie; Joseph Jankovic πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 55 KB πŸ‘ 3 views

genes and who were found to be negative. 1 In this group of 122 patients, we identified 5 patients with an FMR1 premutation and in 4 of them a definite diagnosis of fragile Xassociated tremor/ataxia syndrome (FXTAS) could be made, based on the proposed diagnostic criteria for FXTAS. We proposed base

Clinical and pathological characteristic
Clinical and pathological characteristics of patients with Leucine-rich repeat kinase-2 mutations
✍ Jason P. Covy; Wuxing Yuan; Elisa A. Waxman; Howard I. Hurtig; Vivianna M. Van D πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 256 KB

## Abstract Mutations in LRRK2 are the single most common known cause of Parkinson's disease (PD). Two new PD patients with LRRK2 mutation were identified from a cohort with extensive postmortem assessment. One of these patients harbors the R793M mutation and presented with the typical clinical and